Comorbidities in patients with Unverricht–Lundborg disease (EPM1)

Background Unverricht‐Lundborg disease (EPM1) typically leads to accumulating disability. Disability may also be caused by comorbidities but there are no data available on these. Aims of the Study To investigate the frequency of comorbidities in EPM1. Methods Comorbidity data of a previously describ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta neurologica Scandinavica 2022-11, Vol.146 (5), p.690-693
Hauptverfasser: Sipilä, Jussi O. T., Kälviäinen, Reetta
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 693
container_issue 5
container_start_page 690
container_title Acta neurologica Scandinavica
container_volume 146
creator Sipilä, Jussi O. T.
Kälviäinen, Reetta
description Background Unverricht‐Lundborg disease (EPM1) typically leads to accumulating disability. Disability may also be caused by comorbidities but there are no data available on these. Aims of the Study To investigate the frequency of comorbidities in EPM1. Methods Comorbidity data of a previously described cohort of 135 Finnish patients with EPM1 were retrieved from neurological, surgical (including subspecialities), internal medicine (including subspecialities) and intensive care patient charts of the treating hospitals. Results Mean follow‐up time was 31.4 years (SD 12.4 years, range 6.8–57.8 years), during which at least one comorbidity was observed in 107 patients (79%) and three or more in 53 (39%). The most common diagnostic categories were external injuries, mental and behavioural disorders and endocrine, nutritional and metabolic diseases. The most common single comorbid diagnosis was a fracture of the ankle (in 19% of all patients). The second most common single comorbid diagnosis in the cohort was diabetes (in 13% of all patients), and the third was depression, recorded for 13% of the cohort. Malignancies and cardiovascular end‐organ damage were rare, whereas phimosis/paraphimosis appeared more common than in general population. Conclusions Patients with EPM1 often have comorbidities. Trauma and mental health risks should be especially followed and acted upon. Further studies are needed to more accurately comorbidity risks, characteristics and patient needs.
doi_str_mv 10.1111/ane.13706
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9826374</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2714065179</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3586-4962984bf8252dc2ae8f064d3c0c21206f5a54b30527e46b0286b7ca32ce5c9c3</originalsourceid><addsrcrecordid>eNp1kU1O3DAYhi3Uqgy0Cy6AInUDi8Dnn9jOBgkNA1QaaBdlbTmOwxhl4qmdgNhxBy7AWTgKJ8EwgCgS3tiWHz16P78IbWDYwWnt6s7uYCqAr6AR5gA5MGBf0AgAcM4pZqtoLcaLdCOCsW9olXIohaTlCB2M_dyHytWudzZmrssWOp26PmZXrp9lZ92lDcGZWf9wczsdurry4TyrXbQ62vu7rcmfE7z9HX1tdBvtj5d9HZ0dTv6Oj_Pp76Nf4_1pbmghec5KTkrJqkaSgtSGaCsb4KymBgzBBHhT6IJVFAoiLOMVEMkrYTQlxhamNHQd7S29i6Ga29qkmEG3ahHcXIdr5bVT_790bqbO_aUqJeFUsCTYehEE_2-wsVdzF41t2_SDfoiKCMyAF1iUCf35Ab3wQ-jSeIkijDEBUiZqe0mZ4GMMtnkLg0E9daOSWT13k9jN9-nfyNcyErC7BK5ca68_N6n908lS-QgeDJkn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2724447088</pqid></control><display><type>article</type><title>Comorbidities in patients with Unverricht–Lundborg disease (EPM1)</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Sipilä, Jussi O. T. ; Kälviäinen, Reetta</creator><creatorcontrib>Sipilä, Jussi O. T. ; Kälviäinen, Reetta</creatorcontrib><description>Background Unverricht‐Lundborg disease (EPM1) typically leads to accumulating disability. Disability may also be caused by comorbidities but there are no data available on these. Aims of the Study To investigate the frequency of comorbidities in EPM1. Methods Comorbidity data of a previously described cohort of 135 Finnish patients with EPM1 were retrieved from neurological, surgical (including subspecialities), internal medicine (including subspecialities) and intensive care patient charts of the treating hospitals. Results Mean follow‐up time was 31.4 years (SD 12.4 years, range 6.8–57.8 years), during which at least one comorbidity was observed in 107 patients (79%) and three or more in 53 (39%). The most common diagnostic categories were external injuries, mental and behavioural disorders and endocrine, nutritional and metabolic diseases. The most common single comorbid diagnosis was a fracture of the ankle (in 19% of all patients). The second most common single comorbid diagnosis in the cohort was diabetes (in 13% of all patients), and the third was depression, recorded for 13% of the cohort. Malignancies and cardiovascular end‐organ damage were rare, whereas phimosis/paraphimosis appeared more common than in general population. Conclusions Patients with EPM1 often have comorbidities. Trauma and mental health risks should be especially followed and acted upon. Further studies are needed to more accurately comorbidity risks, characteristics and patient needs.</description><identifier>ISSN: 0001-6314</identifier><identifier>EISSN: 1600-0404</identifier><identifier>DOI: 10.1111/ane.13706</identifier><identifier>PMID: 36097839</identifier><language>eng</language><publisher>Denmark: Hindawi Limited</publisher><subject>Ankle ; Clinical ; clinical neurology ; Cohort Studies ; Comorbidity ; Diabetes mellitus ; Diagnosis ; epileptic syndromes ; Finland - epidemiology ; hereditary disorders ; Humans ; Male ; Metabolic disorders ; Patients ; rare epilepsies ; Trauma ; Unverricht-Lundborg Syndrome - pathology</subject><ispartof>Acta neurologica Scandinavica, 2022-11, Vol.146 (5), p.690-693</ispartof><rights>2022 The Authors. published by John Wiley &amp; Sons Ltd.</rights><rights>2022 The Authors. Acta Neurologica Scandinavica published by John Wiley &amp; Sons Ltd.</rights><rights>2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3586-4962984bf8252dc2ae8f064d3c0c21206f5a54b30527e46b0286b7ca32ce5c9c3</citedby><cites>FETCH-LOGICAL-c3586-4962984bf8252dc2ae8f064d3c0c21206f5a54b30527e46b0286b7ca32ce5c9c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fane.13706$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fane.13706$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36097839$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sipilä, Jussi O. T.</creatorcontrib><creatorcontrib>Kälviäinen, Reetta</creatorcontrib><title>Comorbidities in patients with Unverricht–Lundborg disease (EPM1)</title><title>Acta neurologica Scandinavica</title><addtitle>Acta Neurol Scand</addtitle><description>Background Unverricht‐Lundborg disease (EPM1) typically leads to accumulating disability. Disability may also be caused by comorbidities but there are no data available on these. Aims of the Study To investigate the frequency of comorbidities in EPM1. Methods Comorbidity data of a previously described cohort of 135 Finnish patients with EPM1 were retrieved from neurological, surgical (including subspecialities), internal medicine (including subspecialities) and intensive care patient charts of the treating hospitals. Results Mean follow‐up time was 31.4 years (SD 12.4 years, range 6.8–57.8 years), during which at least one comorbidity was observed in 107 patients (79%) and three or more in 53 (39%). The most common diagnostic categories were external injuries, mental and behavioural disorders and endocrine, nutritional and metabolic diseases. The most common single comorbid diagnosis was a fracture of the ankle (in 19% of all patients). The second most common single comorbid diagnosis in the cohort was diabetes (in 13% of all patients), and the third was depression, recorded for 13% of the cohort. Malignancies and cardiovascular end‐organ damage were rare, whereas phimosis/paraphimosis appeared more common than in general population. Conclusions Patients with EPM1 often have comorbidities. Trauma and mental health risks should be especially followed and acted upon. Further studies are needed to more accurately comorbidity risks, characteristics and patient needs.</description><subject>Ankle</subject><subject>Clinical</subject><subject>clinical neurology</subject><subject>Cohort Studies</subject><subject>Comorbidity</subject><subject>Diabetes mellitus</subject><subject>Diagnosis</subject><subject>epileptic syndromes</subject><subject>Finland - epidemiology</subject><subject>hereditary disorders</subject><subject>Humans</subject><subject>Male</subject><subject>Metabolic disorders</subject><subject>Patients</subject><subject>rare epilepsies</subject><subject>Trauma</subject><subject>Unverricht-Lundborg Syndrome - pathology</subject><issn>0001-6314</issn><issn>1600-0404</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp1kU1O3DAYhi3Uqgy0Cy6AInUDi8Dnn9jOBgkNA1QaaBdlbTmOwxhl4qmdgNhxBy7AWTgKJ8EwgCgS3tiWHz16P78IbWDYwWnt6s7uYCqAr6AR5gA5MGBf0AgAcM4pZqtoLcaLdCOCsW9olXIohaTlCB2M_dyHytWudzZmrssWOp26PmZXrp9lZ92lDcGZWf9wczsdurry4TyrXbQ62vu7rcmfE7z9HX1tdBvtj5d9HZ0dTv6Oj_Pp76Nf4_1pbmghec5KTkrJqkaSgtSGaCsb4KymBgzBBHhT6IJVFAoiLOMVEMkrYTQlxhamNHQd7S29i6Ga29qkmEG3ahHcXIdr5bVT_790bqbO_aUqJeFUsCTYehEE_2-wsVdzF41t2_SDfoiKCMyAF1iUCf35Ab3wQ-jSeIkijDEBUiZqe0mZ4GMMtnkLg0E9daOSWT13k9jN9-nfyNcyErC7BK5ca68_N6n908lS-QgeDJkn</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Sipilä, Jussi O. T.</creator><creator>Kälviäinen, Reetta</creator><general>Hindawi Limited</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202211</creationdate><title>Comorbidities in patients with Unverricht–Lundborg disease (EPM1)</title><author>Sipilä, Jussi O. T. ; Kälviäinen, Reetta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3586-4962984bf8252dc2ae8f064d3c0c21206f5a54b30527e46b0286b7ca32ce5c9c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Ankle</topic><topic>Clinical</topic><topic>clinical neurology</topic><topic>Cohort Studies</topic><topic>Comorbidity</topic><topic>Diabetes mellitus</topic><topic>Diagnosis</topic><topic>epileptic syndromes</topic><topic>Finland - epidemiology</topic><topic>hereditary disorders</topic><topic>Humans</topic><topic>Male</topic><topic>Metabolic disorders</topic><topic>Patients</topic><topic>rare epilepsies</topic><topic>Trauma</topic><topic>Unverricht-Lundborg Syndrome - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sipilä, Jussi O. T.</creatorcontrib><creatorcontrib>Kälviäinen, Reetta</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta neurologica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sipilä, Jussi O. T.</au><au>Kälviäinen, Reetta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comorbidities in patients with Unverricht–Lundborg disease (EPM1)</atitle><jtitle>Acta neurologica Scandinavica</jtitle><addtitle>Acta Neurol Scand</addtitle><date>2022-11</date><risdate>2022</risdate><volume>146</volume><issue>5</issue><spage>690</spage><epage>693</epage><pages>690-693</pages><issn>0001-6314</issn><eissn>1600-0404</eissn><abstract>Background Unverricht‐Lundborg disease (EPM1) typically leads to accumulating disability. Disability may also be caused by comorbidities but there are no data available on these. Aims of the Study To investigate the frequency of comorbidities in EPM1. Methods Comorbidity data of a previously described cohort of 135 Finnish patients with EPM1 were retrieved from neurological, surgical (including subspecialities), internal medicine (including subspecialities) and intensive care patient charts of the treating hospitals. Results Mean follow‐up time was 31.4 years (SD 12.4 years, range 6.8–57.8 years), during which at least one comorbidity was observed in 107 patients (79%) and three or more in 53 (39%). The most common diagnostic categories were external injuries, mental and behavioural disorders and endocrine, nutritional and metabolic diseases. The most common single comorbid diagnosis was a fracture of the ankle (in 19% of all patients). The second most common single comorbid diagnosis in the cohort was diabetes (in 13% of all patients), and the third was depression, recorded for 13% of the cohort. Malignancies and cardiovascular end‐organ damage were rare, whereas phimosis/paraphimosis appeared more common than in general population. Conclusions Patients with EPM1 often have comorbidities. Trauma and mental health risks should be especially followed and acted upon. Further studies are needed to more accurately comorbidity risks, characteristics and patient needs.</abstract><cop>Denmark</cop><pub>Hindawi Limited</pub><pmid>36097839</pmid><doi>10.1111/ane.13706</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0001-6314
ispartof Acta neurologica Scandinavica, 2022-11, Vol.146 (5), p.690-693
issn 0001-6314
1600-0404
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9826374
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Ankle
Clinical
clinical neurology
Cohort Studies
Comorbidity
Diabetes mellitus
Diagnosis
epileptic syndromes
Finland - epidemiology
hereditary disorders
Humans
Male
Metabolic disorders
Patients
rare epilepsies
Trauma
Unverricht-Lundborg Syndrome - pathology
title Comorbidities in patients with Unverricht–Lundborg disease (EPM1)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T19%3A22%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comorbidities%20in%20patients%20with%20Unverricht%E2%80%93Lundborg%20disease%C2%A0(EPM1)&rft.jtitle=Acta%20neurologica%20Scandinavica&rft.au=Sipil%C3%A4,%20Jussi%20O.%20T.&rft.date=2022-11&rft.volume=146&rft.issue=5&rft.spage=690&rft.epage=693&rft.pages=690-693&rft.issn=0001-6314&rft.eissn=1600-0404&rft_id=info:doi/10.1111/ane.13706&rft_dat=%3Cproquest_pubme%3E2714065179%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2724447088&rft_id=info:pmid/36097839&rfr_iscdi=true